Linda C. Hogan, Head, Business Development and Strategy at CoLucid Pharmaceuticals, Inc. (CLCD), sold 719 shares at $30.00 ($22K) on 2016-11-01, disclosed to the SEC on 2016-11-01.
Scheduled sale ($22k) by Head, Business Development and Strategy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLCD | SELL | 2016-11-07 | $53K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $96K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $969K | — | Filing → |